Jessica Sayers

Jessica Sayers

Auto-generated profile, based on publicly available information

Jessica Sayers

Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Chem
Verified
Journal Article
Closed access
NMNicholas J. Mitchell
Nicholas J. Mitchell
JSJessica Sayers
Jessica Sayers
SKSameer S. Kulkarni
Sameer S. Kulkarni
DCDaniel Clayton
Daniel Clayton
AGAnna M. Goldys
Anna M. Goldys
RPRichard J. Payne
Richard J. Payne

21 September 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JSJessica Sayers
Jessica Sayers
PKPhillip M. T. Karpati
Phillip M. T. Karpati
NMNicholas J. Mitchell
Nicholas J. Mitchell
AGAnna M. Goldys
Anna M. Goldys
SKStephen M. Kwong
Stephen M. Kwong
RPRichard J. Payne
Richard J. Payne

22 November 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
JSJessica Sayers
Jessica Sayers
RPRichard J. Payne
Richard J. Payne
NWNicolas Winssinger
Nicolas Winssinger
A PNA-templated peptide ligation reaction has been developed between selenocystine and selenoesters. The methodology was used for the sequence specific detection of miRNA at low concentrations.

23 September 2015 in Organic Letters
Verified
Journal Article
Closed access
JSJessica Sayers
Jessica Sayers
RTRobert E. Thompson
Robert E. Thompson
KPKristen J. Perry
Kristen J. Perry
LMLara R. Malins
Lara R. Malins
RPRichard J. Payne
Richard J. Payne

20 June 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
EWEmma Elizabeth Watson
Emma Elizabeth Watson
JRJorge Ripoll-Rozada
Jorge Ripoll-Rozada
ALAshley C. Lee
Ashley C. Lee
MWMike C. L. Wu
Mike C. L. Wu
CFCharlotte Franck
Charlotte Franck
RPRichard J. Payne
Richard J. Payne
Significance: Cardiovascular disease represents a significant health challenge, with towering economic and social costs resulting from the high levels of associated morbidity and mortality. For conditions resulting from undesired blood clotting, treatment options remain limited and are accompanied by significant side effects. Using a rapid chemical ligation platform, 34 homogeneously modified variants of tick anticoagulant proteins were generated. Access to this synthetic protein library enabled key structure–activity relationships to be elucidated and revealed unexpected differences in the mechanism of thrombin inhibition by this group of otherwise closely related molecules. The synthetic platform reported here provides a unique means to expedite the generation and identification of polypeptide and protein therapeutic leads for clotting-associated diseases.

16 June 2024 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
AOAniekan Okon
Aniekan Okon
JYJinyi Yang
Jinyi Yang
JGJoLynn B. Giancola
JoLynn B. Giancola
OMOscar J. Molina
Oscar J. Molina
JSJessica Sayers
Jessica Sayers
RRRonald T. Raines
Ronald T. Raines